Similar articles

Abstract: T help cell 17 (th17), recently identified as a new subset of CD4⁺ T cells, has been implicated in autoimmune diseases, tumor immunity, and transplant rejection. To investigate the role of th17 in acute hepatic rejection, a rat model of allogeneic liver transplantation (Dark Agouti (DA) to Brown Norway (BN)) was established and isogeneic liver transplantation (BN to BN) was used as controls in the study. The expression of th17-related cytokines in the liver and peripheral blood was determined by immunohistochemistry, flow cytometry, enzyme-linked immunosorbent assay (ELISA), or real-time quantitative reverse transcription polymerase chain reaction (RT-qPCR). Strong expression of interleukin-17A (IL-17A), IL-6, transforming growth factor-β (TGF-β), IL-8, and myeloperoxidase (MPO) was observed in liver allografts. The ratios of th17 to CD4⁺ lymphocytes in the liver and peripheral blood were dramatically increased in the allograft group compared with the control (P<0.01). Secreted IL-17 and IL-6 in liver homogenate and serum were significantly elevated in the allograft group, while secreted TGF-β was increased in liver homogenate and decreased in serum compared with the control (P<0.01). The messenger RNA (mRNA) levels of IL-17, IL-21, and IL-23 were enhanced in the allografts compared with the control (P<0.01). Correlation analysis showed significant correlations between IL-17 and IL-6 and TGF-β and between IL-17 and IL-21 and IL-23. The present study demonstrates that th17 plays a role in promoting rat liver allograft rejection.

[1]Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T.B., Oukka, M., Weiner, H.L., Kuchroo, V.K., 2006. Reciprocal developmental pathways for the generation of pathogenic effector Th17 and regulatory T cells. Nature, 441(7090):235-238.

[2]Chen, H., Wang, W., Xie, H., Xu, X., Wu, J., Jiang, Z., Zhang, M., Zhou, L., Zheng, S., 2009. A pathogenic role of IL-17 at the early stage of corneal allograft rejection. Transpl. Immunol., 21(3):155-161.

[3]Chen, L., Ahmed, E., Wang, T., Wang, Y., Ochando, J., Chong, A.S., Alegre, M.L., 2009. TLR signals promote IL-6/ IL-17-dependent transplant rejection. J. Immunol., 182(10):6217-6225.

[4]Chen, W.J., Jin, W.W., Hardegen, N., Lei, K.J., Li, L., Marinos, N., McGrady, G., Wahl, S.M., 2003. Conversion of peripheral CD4⁺CD25⁻ naive T cells to CD4⁺CD25⁺ regulatory T cells by TGF-β induction of transcription factor Foxp3. J. Exp. Med., 198(12):1875-1886.

[5]Demetrius, A.J., Batts, K.P., Dhillon, A.P., Ferrell, L., Fung, J., Geller, S.A., Hart, J., Hayry, P., Hofmann, W.J., Hubscher, S., et al., 1997. Banff schema for grading liver allograft rejection: an international consensus document. Hepatology, 25(3):658-663.

[6]Demirkiran, A., Kok, A., Kwekkeboom, J., Kusters, J.G., Metselaar, H.J., Tilanus, H.W., van der Laan, L.J., 2006. Low circulating regulatory T-cell levels after acute rejection in liver transplantation. Liver Transpl., 12(2):277-284.

[7]Fábrega, E., Lopez-Hoyos, M., San-Segundo, D., Casafont, F., Pons-Romero, F., 2009. Changes in the serum levels of interleukin-17/interleukin-23 during acute rejection in liver transplantation. Liver Transpl., 15(6):629-633.

[8]Halloran, P.F., Miller, L.W., Urmson, J., Ramassar, V., Zhu, L.F., Kneteman, N.M., Solez, K., Afrouzian, M., 2001. IFN-γ alters the pathology of graft rejection: protection from early necrosis. J. Immunol., 166(12):7072-7081.

[9]Hoshino, H., Laan, M., Sjostrand, M., Lotvall, J., Skoogh, B.E., Linden, A., 2000. Increased elastase and myeloperoxidase activity associated with neutrophil recruitment by IL-17 in airways in vivo. J. Allergy Clin. Immunol., 105(1):143-149.

[10]Hsieh, H.G., Loong, C.C., Lui, W.Y., Chen, A., Lin, C.Y., 2001. IL-17 expression as a possible predictive parameter for subclinical renal allograft rejection. Transpl. Int., 14(5):287-298.

[11]Kamada, N., 1988. Experimental Liver Transplantation. CRC Press, Boca Raton, FL, p.55-66.

[12]Kamada, N., Calne, R.Y., 1979. Orthotopic liver transplantation in the rat. Technique using cuff for portal vein anastomosis and biliary drainage. Transplantation, 28(1):47-50.

[13]Kishimoto, T., 1989. The biology of interleukin-6. Blood, 74(1):1-10.

[14]Kita, Y., Iwaki, Y., Demetris, A.J., Starzl, T.E., 1994. Evaluation of sequential serum interleukin-6 levels in liver allograft recipients. Transplantation, 57(7):1037-1041.

[15]Kolls, J.K., Linden, A., 2004. Interleukin-17 family members and inflammation. Immunity, 21(4):467-476.

[16]Laan, M., Cui, Z.H., Hoshino, H., Lötvall, J., Sjöstrand, M., Gruenert, D.C., Skoogh, B.E., Lindén, A., 1999. Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. J. Immunol., 162(4):2347-2352.

[17]Li, M.O., Wan, Y.Y., Sanjabi, S., Robertson, A.K., Flavell, R.A., 2006. Transforming growth factor-beta regulation of immune responses. Annu. Rev. Immunol., 24(1):99-146.

[18]Loong, C.C., Hsieh, H.G., Lui, W.Y., Chen, A., Lin, C.Y., 2002. Evidence for the early involvement of interleukin 17 in human and experimental renal allograft rejection. J. Pathol., 197(3):322-332.

[19]Malik, R., Selden, C., Hodgson, H., 2002. The role of non-parenchymal cells in liver growth. Semin. Cell Dev. Biol., 13(6):425-431.

[20]Mangan, P.R., Harrington, L.E., O′Quinn, D.B., Helms, W.S., Bullard, D.C., Elson, C.O., Hatton, R.D., Wahl, S.M., Schoeb, T.R., Weaver, C.T., 2006. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature, 441(7090):231-234.

[21]Miura, M., El-Sawy, T., Fairchild, R.L., 2003. Neutrophils mediate parenchymal tissue necrosis and accelerate the rejection of complete major histocompatibility complex-disparate cardiac allografts in the absence of interferon-gamma. Am. J. Pathol., 162(2):509-519.

[22]Nurieva, R., Yang, X.O., Martinez, G., Zhang, Y., Panopoulos, A.D., Ma, L., Schluns, K., Tian, Q., Watowich, S.S., Jetten, A.M., et al., 2007. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature, 448(7152):480-483.

[23]Obata, F., Yoshida, K., Ohkubo, M., Ikeda, Y., Taoka, Y., Takeuchi, Y., Shinohara, N., Endo, T., Baba, S., 2005. Contribution of CD4⁺ and CD8⁺ T cells and interferon-γ to the progress of chronic rejection of kidney allografts: the Th1 response mediates both acute and chronic rejection. Transpl. Immunol., 14(1):21-25.

[24]Prause, O., Laan, M., Lotvall, J., Linden, A., 2003. Pharmacological modulation of interleukin-17-induced GCP-2-, GRO-α- and interleukin-8 release in human bronchial epithelial cells. Eur. J. Pharmacol., 462(1-3):193-198.

[25]Reiner, S.L., 2007. Development in motion: helper T cells at work. Cell, 129(1):33-36.

[26]Saiura, A., Mataki, C., Murakami, T., Umetani, M., Wada, Y., Kohro, T., Aburatani, H., Harihara, Y., Hamakubo, T., Yamaguchi, T., et al., 2001. A comparison of gene expression in murine cardiac allografts and isografts by means DNA microarray analysis. Transplantation, 72(2):320-329.

[27]Stritesky, G.L., Yeh, N., Kaplan, M.H., 2008. IL-23 promotes maintenance but not commitment to the Th17 lineage. J. Immunol., 181(9):5948-5955.

[28]Vanaudenaerde, B.M., de Vleeschauwer, S.I., Vos, R., Meyts, I., Bullens, D.M., Reynders, V., Wuyts, W.A., van Raemdonck, D.E., Dupont, L.J., Verleden, G.M., 2008. The role of the IL23/IL17 axis in bronchiolitis obliterans syndrome after lung transplantation. Am. J. Transplant., 8(9):1911-1920.

[29]Wadia, P.P., Tambur, A.R., 2008. Yin and yan of cytokine regulation in solid organ graft rejection and tolerance. Clin. Lab. Med., 28(3):469-479.

[30]Warlé, M.C., Metselaar, H.J., Hop, W.C., Gyssens, I.C., Kap, M., Kwekkeboom, J., de Rave, S., Zondervan, P.E., IJzermans, J.N., Tilanus, H.W., et al., 2003. Early differentiation between rejection and infection in liver transplant patients by serum and biliary cytokine patterns. Transplantation, 75(1):146-151.

[31]Weaver, C.T., Hatton, R.D., Mangan, P.R., Harrington, L.E., 2007. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu. Rev. Immunol., 25(1):821-852.

[32]Xiang, Z., Ma, L.L., Manicassamy, S., Ganesh, B.B., Williams, P., Chari, R., Chong, A., Yin, D.P., 2008. CD4⁺ T cells are sufficient to elicit allograft rejection and major histocompatibility complex class I molecule is required to induce recurrent autoimmune diabetes after pancreas transplantation in mice. Transplantation, 85(8):1205-1211.

[33]Yuan, X., Paez-Cortez, J., Schmitt-Knosalla, I., D′Addio, F., Mfarrej, B., Donnarumma, M., Habicht, A., Clarkson, M.R., Iacomini, J., Glimcher, L.H., et al., 2008. A novel role of CD4 Th17 cells in mediating cardiac allograft rejection and vasculopathy. J. Exp. Med., 205(13):3133-3144.

[34]Yuan, X., Ansari, M.J., D'Addio, F., Paez-Cortez, J., Schmitt, I., Donnarumma, M., Boenisch, O., Zhao, X., Popoola, J., Clarkson, M.R., et al., 2009. Targeting Tim-1 to overcome resistance to transplantation tolerance mediated by CD8 T17 cells. PNAS, 106(26):10734-10739.